Publication Ventajas de administrar dosis altas de clofazimina Butlin CR, Maghanoy AA. Revista de leprología. 2022; 92 (4) : 427-432.
Publication Prognosis of Leprosy Nunzi E. Springer International Publishing. Leprosy and Buruli Ulcer. 2022;
Publication Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: A threat to effective secondary line treatment for rifampicin resistant leprosy cases. Ahuja M, Singh I, Lavania M, et al. Journal of global antimicrobial resistance. 2022; Download PDF
Publication Safer and newer antimicrobial drugs for leprosy – time to test monthly ROM in an adequately powered randomised trial? Lockwood DNJ, Penna GO, Lambert S, et al. Lepra. Leprosy Review. 2022; 93 (2) : 96-101. Download PDF
Publication Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol. Krismawati H, Ferdiana A, Irwanto A, et al. BMJ open. 2022; 12 (5) : e057173. Download PDF
Publication Drug resistance in leprosy: an update following 70 years of chemotherapy. Aubry A, Rosa SP, Chauffour A, et al. Infectious diseases now. 2022; Download PDF
Publication Zero leprosy: A united effort using existing & new tools but new perspectives van Brakel W. Wolters Kluwer. Indian Journal of Medical Research. 2022; Download PDF
Publication Epidemiological and clinical characterization of paraguayan patients with leprosy and household contacts before and after treatment with multi-drug therapy Maiz GE, Rojas LE, Pereira JG, et al. Instituto de Investigaciones en Ciencias de la Salud. Anales de la Facultad de Ciencias Médicas (Asunción). 2022; 55 (1) : 49-62. Download PDF
Publication FARMACOTERAPIA APLICADA ÀS REAÇÕES IMUNOLÓGICAS DA HANSENÍASE Da Silva PA, Peres JG, Freitas IKEV, et al. RECIMA21 - Revista Cientifica Multidisciplinar. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. 2022; 3 (4) : e341340. Download PDF
Publication The Experiences of Leprosy Clients Attending Self-Care Groups During Community-Based Rehabilitation for Fulfilling Their Health Needs Susanto T, Bahtiar S, Deviantony F, et al. Indian Journal of Leprosy. 2022; Download PDF
Publication An Overview of Treatment Guidelines and Methods of Synthesis of Drugs Used in Leprosy Chemotherapy. Pinheiro L, Borges J, Campos V, et al. Mini reviews in medicinal chemistry. 2022;
Publication Innovative drug delivery systems for leprosy treatment. da Rocha N, Barbosa E, de Araujo G, et al. Indian journal of dermatology, venereology and leprology. 2022; Download PDF
Publication Innovative drug delivery systems for leprosy treatment da Rocha NP, Barbosa EJ, Barros de Araujo GL, et al. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2022; Download PDF
Publication Peran Disregulasi Imunitas dalam Terapi Kusta pada Area Endemis: Artikel Review Prakoeswa FRS, Maharani F. Faculty of Pharmacy, Mulawarman University. Jurnal Sains dan Kesehatan. 2022; 4 (1) : 99-104. Download PDF
Publication Single-lesion paucibacillary leprosy: a retrospective study of 75 cases treated with the ROM scheme. Pennini SN, França J, Rebello P, et al. Anais brasileiros de dermatologia. 2022; Download PDF
Publication Follow-up assessment of patients with Pure Neural Leprosy in a reference center in Rio de Janeiro-Brazil. Pitta IJR, Hacker M, Andrade L, et al. PLoS neglected tropical diseases. 2022; 16 (1) : e0010070. Download PDF
Publication Leprosy Relapse: a Retrospective Study on Epidemiological, Clinical and Therapeutics Aspects at a Brazilian Referral Center. Nascimento A, Santos D, Antunes D, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2022; Download PDF
Publication [Late diagnosis nodular lepromatous leprosy from the Peruvian Amazon, with development of a type 2 reaction]. Villegas-Chiroque M, Maldonado-Gómez W, Espino-Saavedra W, et al. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia. 2021; 38 (5) : 707-712. Download PDF
Publication LA DURACIÓN ACTUAL DE UN AÑO PARA LA POLIQUIMIOTERAPIA DE LOS PACIENTES MB (12 MESES) MANTIENE BUENOS RESULTADOS CLÍNICOS DURANTE AÑOS Lockwood D, Butlin CR, Penna GO. Fontilles. Revista de leprología. 2021; 33 (2) : 133-138.
